Cryoprecipitated Antihemophilic Factor from Human Plasma from Canada
Cryoprecipitate is a human plasma fraction rich in factor VIII, fibrinogen, and von Willebrand factor, prepared by thawing frozen plasma at 1-6°C. It treats hemophilia A and fibrinogen deficiencies. Falls under HTS 3002.12.00.10 as a human blood fraction derived from plasma.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide CBER registration and lot-specific release certificates from FDA-licensed fractionators
• Declare exact protein content and potency per unit to avoid misclassification during entry
• Watch for expiration dating issues; expired plasma risks waste pharmaceutical classification under 3006